Our study reveals a novel regulatory axis of DDP resistance in ovarian cancer cells and suggests promising targets (i.e., HSPA8, CLPP, and mitochondrial protein homeostasis) for overcoming DDP resistance. This evidence concerns the gene HSPA8 and ovarian carcinoma.